Dr. Foody is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
75 Francis St
Boston, MA 02115Phone+1 857-307-1989Fax+1 857-307-1955
Education & Training
- Cleveland Clinic FoundationFellowship, Cardiovascular Disease, 1996 - 2000
- Brigham and Women's HospitalResidency, Internal Medicine, 1990 - 1993
- University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1990
Certifications & Licensure
- MA State Medical License 1992 - 2024
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
- Whos Who in Medicine and Healthcare Marquis Whos Who
- Fellow (FACC) American College of Cardiology
Publications & Presentations
PubMed
- 76 citationsSleep Disturbances Time to Join the Top 10 Potentially Modifiable Cardiovascular Risk FactorsSusan Redline, JoAnne M. Foody
Circulation. 2011-11-08 - 80 citationsHealth Outcome Priorities Among Competing Cardiovascular, Fall Injury, and Medication-Related Symptom OutcomesMary E. Tinetti, Gail McAvay, Terri R. Fried, Heather G. Allore, JoAnna C. Salmon
Journal of the American Geriatrics Society. 2008-08-01 - 23 citationsTroponin-positive, MB-negative patients with non-ST-elevation myocardial infarction: An undertreated but high-risk patient group: Results from the National Cardiovascu...Michael C. Kontos, James A. de Lemos, Fang Shu Ou, Stephan D. Wiviott, JoAnne M. Foody
American Heart Journal. 2010-11-01
Press Mentions
- European Commission Approves Yuvanci® (Single Tablet Combination Therapy [STCT] of Macitentan and Tadalafil) for Treatment of Patients with Pulmonary Arterial Hypertension (PAH)September 30th, 2024
- Landmark CLEAR Outcomes Study Demonstrates NEXLETOL (Bempedoic Acid) Tablet Is the Only LDL-C Lowering Therapy Since Statins to Reduce Hard Ischemic Events in a Broad PopulationApril 3rd, 2023
- LDL May Be an Alternative to StatinsMarch 5th, 2023
- Join now to see all
Grant Support
- Lipid Testing /Treatment In Older MI PatientsNational Institute On Aging2002–2005
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: